Predicting Drug Safety and Risk, Boston, MA, USA
Event May 23
CBI's Predicting Drug Safety and Risk – Application of Systems-Based Omics Technologies to Reduce Attrition Rates and the Costs of Drug Discovery is designed to help companies to achieve this goal – to innovate and modernize drug safety tools and practices so that compounds may be screened more effectively and quickly in discovery as opposed to down the line when costs and risks are greater. Above all else, the company must avoid a situation where a drug that has been through clinical trials and approved for marketing has to be withdrawn from the marketplace due to unacceptable adverse drug effects.
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018